Atara Biotherapeutics (ATRA) PT Lowered to $4.80 at Stifel
Tweet
Share
E-mailGet Alerts ATRA Hot Sheet
Price: $9.60 +10.09%
Rating Summary:
5 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 8
Rating Summary:
5 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 8
Join SI Premium – FREE
Stifel analyst Benjamin Burnett lowered the price target on Atara Biotherapeutics (NASDAQ: ATRA) to $4.80 (from $4.90) while maintaining a Hold rating.
You May Also Be Interested In
- Barclays Upgrades Crown Castle (CCI) to Overweight
- Bank of Nova Scotia (BNS:CN) (BNS) PT Raised to Cdn$136 at CIBC
- Target (TGT) PT Raised to $185 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
